- Bevorzugter Name
- Slc13A5-IN-1
- IUPAC
- N-[(4-chlorophenyl)methyl]-1-(3,5-dichlorophenyl)sulfonylpiperidine-4-carboxamide
- Englischer Name
- SLC13A5-IN-1
- Summenformel
- C19H19Cl3N2O3S
- Molmasse
- 461.79
Namen und Synonyme
SLC13A5-IN-12227548-95-8N-(4-Chlorobenzyl)-1-((3,5-dichlorophenyl)sulfonyl)piperidine-4-carboxamideorb1309087CHEMBL5723572SCHEMBL20258718EX-A7538EBC-46303AKOS040738401DA-67629TS-07897HY-125990
Weitere Namen anzeigen
SLC13A5-IN-1, 10 mM in DMSON-[(4-chlorophenyl)methyl]-1-(3,5-dichlorobenzen esulfonyl)piperidine-4-carboxamide4-Piperidinecarboxamide, N-[(4-chlorophenyl)methyl]-1-[(3,5-dichlorophenyl)sulfonyl]-hSLC3A5,metabolic,SLC-13A5-IN-1,SLC13A5IN1,Inhibitor,Citrate,SLC13A5,cardiovascular,inhibit,disease,Sodium Channel,Uptake,Na channels,Na+ channels,SLC13A5 IN 1
CS-0103855G71913T12931Z4606858314N-[(4-chlorophenyl)methyl]-1-(3,5-dichlorophenyl)sulfonylpiperidine-4-carboxamide
Datenbank-Bezeichner
- ChEMBL
CHEMBL5723572